Windtree Therapeutics (WINT) News Today → He called Apple at $1.49 and now he says: “Buy these 6 AI stocks.” (From InvestorPlace) (Ad) Free WINT Stock Alerts $4.49 +0.19 (+4.42%) (As of 05/17/2024 08:54 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 12, 2024 | americanbankingnews.comWindtree Therapeutics, Inc. (NASDAQ:WINT) Short Interest UpdateMay 10, 2024 | americanbankingnews.comWindtree Therapeutics (NASDAQ:WINT) vs. Sangamo Therapeutics (NASDAQ:SGMO) Financial ReviewMay 9, 2024 | msn.comWindtree Therapeutics Regains Nasdaq Compliance with Minimum Bid Price RequirementMay 7, 2024 | finance.yahoo.comWindtree Therapeutics Regains Compliance with NasdaqMay 7, 2024 | marketbeat.comTrading was temporarily halted for "WINT" at 10:05 AM with a stated reason of "LULD pause."May 4, 2024 | morningstar.comWindtree Therapeutics Inc WINTApril 22, 2024 | bizjournals.comWindtree Therapeutics is dangerously low on cashApril 22, 2024 | marketbeat.comTrading was temporarily halted for "WINT" at 07:04 PM with a stated reason of "News pending."April 21, 2024 | msn.comWindtree Therapeutics Announces Reverse Stock Split in Strategy to Boost Market ComplianceApril 18, 2024 | msn.comWhy Windtree Therapeutics (WINT) Stock Is Getting HammeredApril 18, 2024 | globenewswire.comWindtree Therapeutics Announces Reverse Stock SplitApril 17, 2024 | finance.yahoo.comWindtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business UpdatesApril 17, 2024 | globenewswire.comWindtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business UpdatesApril 9, 2024 | finanznachrichten.deWindtree Therapeutics: Windtree Acquires Early-Stage, Novel Oncology Platform and Completes $1.5 Million Convertible Note Bridge FinancingApril 8, 2024 | globenewswire.comWindtree Acquires Early-Stage, Novel Oncology Platform and Completes $1.5 Million Convertible Note Bridge FinancingFebruary 2, 2024 | msn.comWindtree Therapeutics Seeks Strategic Alternatives with Ladenburg ThalmannFebruary 1, 2024 | finance.yahoo.comWindtree Renews Agreement with Chang Gung University for Scientific Collaboration to Further SERCA2a ResearchJanuary 31, 2024 | bizjournals.comWindtree Therapeutics hires investment bank to explore M&A optionsJanuary 31, 2024 | finance.yahoo.comWindtree Therapeutics Announces Engagement of Strategic Advisor to Support Assessment of Strategic AlternativesJanuary 29, 2024 | benzinga.comWindtree Therapeutics – This Biotech Inks License Deal For Lead CandidateJanuary 26, 2024 | finanznachrichten.deWindtree Therapeutics Eliminates $15 Million Contingent Liability To Deerfield Management CompanyJanuary 26, 2024 | finance.yahoo.comWindtree Therapeutics (NASDAQ:WINT) Eliminates $15 Million Contingent Liability To Deerfield Management CompanyJanuary 25, 2024 | benzinga.comWindtree Therapeutics (NASDAQ: WINT) Eliminates $15 Million Contingent Liability To Deerfield Management CompanyJanuary 25, 2024 | finance.yahoo.comWindtree Eliminates $15 Million Contingent Liability to Deerfield Management CompanyJanuary 24, 2024 | money.usnews.comWindtree Therapeutics IncJanuary 18, 2024 | msn.comWindtree and Lee’s sign licence deal for heart failure therapyJanuary 18, 2024 | finance.yahoo.comUp To $138 Million in Milestones, Up To Low Double Digit Royalties: Windtree Announces Agreement To Develop And Commercialize Drug Candidates In Greater ChinaJanuary 17, 2024 | bizjournals.comWindtree Therapeutics signs drug licensing deal valued at up to $138M with Chinese drug companyJanuary 17, 2024 | finance.yahoo.comWindtree Therapeutics Announces License Agreement with Lee’s Pharmaceuticals to Develop and Commercialize Istaroxime, Dual Mechanism SERCA2a Activators and Rostafuroxin for Greater China / Asia Pacific RegionJanuary 4, 2024 | markets.businessinsider.comHold Rating on Windtree Therapeutics Pending Key Istaroxime StudiesJanuary 3, 2024 | msn.comHC Wainwright & Co. Initiates Coverage of Windtree Therapeutics (WINT) with Neutral RecommendationJanuary 2, 2024 | markets.businessinsider.comWindtree Therapeutics Announces Reduction In Arrythmias In A New Study With Istaroxime And A Pure SERCA2a ActivatorJanuary 2, 2024 | finance.yahoo.comWindtree Therapeutics Announces Reduction In Arrythmias In A New Study With Istaroxime And A Pure SERCA2a ActivatorDecember 19, 2023 | finance.yahoo.comIstaroxime Update: Start Of Patient Dosing In Early Cardiogenic Shock SEISMiC Extension Study In Preparation For Phase 3 Readiness, Topline Data Expected Mid-2024December 18, 2023 | finance.yahoo.comWindtree Therapeutics Announces the Start of Patient Dosing In Phase 2 SEISMiC Extension Study of Istaroxime in Early Cardiogenic ShockNovember 16, 2023 | finance.yahoo.comWindtree Therapeutics Announces Issuance of New Pure SERCA2a Activator PatentNovember 9, 2023 | msn.comWindtree TherapeuticS GAAP EPS of -$0.86November 9, 2023 | finance.yahoo.comWindtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business UpdatesNovember 8, 2023 | finance.yahoo.comWindtree to Present at the Sidoti Micro Cap Conference on November 16thOctober 12, 2023 | tmcnet.comWindtree to Present at the ThinkEquity Conference on October 19th in New York CityOctober 12, 2023 | finance.yahoo.comWindtree to Present at the ThinkEquity Conference on October 19th in New York CityOctober 10, 2023 | finance.yahoo.comWindtree to Participate in the Lytham Partners Fall 2023 Investor Conference on October 17thOctober 3, 2023 | finance.yahoo.comWindtree to Present at the Dawson James Small Cap Growth Conference on October 12thAugust 23, 2023 | markets.businessinsider.comWindtree Announces Issuance of Composition of Matter Patent for Dual Mechanism SERCA2a Activators by the US Patent and Trademark OfficeAugust 23, 2023 | finance.yahoo.comWindtree Announces Issuance of Composition of Matter Patent for Dual Mechanism SERCA2a Activators by the US Patent and Trademark OfficeAugust 16, 2023 | finance.yahoo.comWindtree Therapeutics (NASDAQ:WINT) Is Developing A Multi-Asset Franchise Of Its Novel SERCA2a Activators In A Multi-Billion Dollar MarketAugust 15, 2023 | benzinga.comHow Windtree Therapeutics (NASDAQ: WINT) Is Developing A Multi-Asset Franchise Of Its Novel SERCA2a ActivatorsAugust 15, 2023 | benzinga.comWindtree Therapeutics (NASDAQ: WINT) Is Developing A Multi-Asset Franchise Of Its Novel SERCA2a Activators In A Multi-Billion Dollar MarketAugust 8, 2023 | finance.yahoo.comWindtree Therapeutics Reports Second Quarter 2023 Financial Results and Provides Key Business UpdatesJuly 25, 2023 | finance.yahoo.comWindtree Therapeutics' (NASDAQ: WINT) Upcoming Istaroxime Development Milestones And Next Generation Drug Candidates Could Produce New Fast Follow-On Line Of Drugs For Heart Failure Get Windtree Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for WINT and its competitors with MarketBeat's FREE daily newsletter. Email Address Global crypto currency reset (41 major banks signed up) (Ad)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. WINT Media Mentions By Week WINT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. WINT News Sentiment▼0.980.42▲Average Medical News Sentiment WINT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. WINT Articles This Week▼01▲WINT Articles Average Week Get Windtree Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for WINT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ELOX News Today ALBT News Today KRBP News Today FNCH News Today TCBP News Today ACOR News Today SCNI News Today SQZ News Today TCON News Today FRTX News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:WINT) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyUrgent Nvidia WarningAltimetryElon’s New Device is About to Shock the WorldInvestorPlace"The Biggest Drug Ever" Is ComingBehind the MarketsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Windtree Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
